Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Compounds from Angelica koreana roots, especially osthenol, could be effective for treating conditions like prostate disease and hair loss.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

Stinging nettle has compounds that help with joint pain, arthritis, and prostate issues.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Dutasteride and finasteride affect different cell types differently.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Finasteride overdose can cause acute pancreatitis.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.